mouse ulbp (R&D Systems)
94
Structured Review
R&D Systems
mouse ulbp
Mouse Ulbp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mult-1/Recombinant+Mouse+ULBP-1%2FMULT-1+Protein/pm38342011-61-0-16
Average 94 stars, based on 1 article reviews
Mouse Ulbp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mult-1/Recombinant+Mouse+ULBP-1%2FMULT-1+Protein/pm38342011-61-0-16
Average 94 stars, based on 1 article reviews
mouse ulbp - by Bioz Stars,
2026-11
94/100 stars
Images
Related Articles
Flow Cytometry:Article Title: Group 1 innate lymphoid cell activation via recognition of NKG2D and liver resident macrophage MULT-1: Collaborated roles in triptolide induced hepatic immunotoxicity in mice. Article Snippet: 2-(4-Amidinophenyl)− 6-indolecarbamidine dihydrochloride (DAPI), Phorbol-12-myristate-13-acetate, Ionomycin and Brefeldin A were purchased from Beyotime Biotech (Shanghai, China). .. Immunocytochemistry:Article Title: Group 1 innate lymphoid cell activation via recognition of NKG2D and liver resident macrophage MULT-1: Collaborated roles in triptolide induced hepatic immunotoxicity in mice. Article Snippet: 2-(4-Amidinophenyl)− 6-indolecarbamidine dihydrochloride (DAPI), Phorbol-12-myristate-13-acetate, Ionomycin and Brefeldin A were purchased from Beyotime Biotech (Shanghai, China). .. In Vivo:Article Title: NK cells propagate T cell immunity following in situ tumor vaccination. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti CD45 PE-Cy7_Attune BioLegend RRID: AB_312978 Anti CD3 FITC_Attune BioLegend RRID: AB_312660 Anti CD4 BV510_Attune BioLegend RRID: AB_2561388 Anti CD8 PerCP-Cy5.5_Attune BioLegend RRID: AB_2075239 Anti NK1.1 BV605_Attune BioLegend RRID: AB_2562273 Anti CD25 BV711_Attune BioLegend RRID: AB_2564130 Anti FOXP3 BV421_Attune BioLegend RRID: AB_2565933 Anti CXCR3 APC_Attune BioLegend RRID: AB_2814077 Anti CD44 BV605_Attune BioLegend RRID: AB_2562451 Anti CD44 BV711_Attune BioLegend RRID: AB_2564214 Anti CD62L AF700_Attune BioLegend RRID: AB_493719 Anti H-2 FITC_Attune BioLegend RRID: AB_1236475 Anti TNFa BV711_Attune BioLegend RRID: AB_2629800 Anti TNFa PE_Attune BioLegend RRID: AB_315426 Anti IFNg APC_Attune BioLegend RRID: AB_315403 Anti PD-L1 PerCP-Cy5.5_Attune BioLegend RRID: AB_2629831 Anti PD-1 BV421_Attune BioLegend RRID: AB_10900085 Anti CD86 blocking Ab_Attune BioLegend RRID: AB_2888740 Anti CD86 PE_Attune BioLegend RRID: AB_2832567 Anti CTLA4 BV421_Attune BioLegend RRID: AB_2616790 Anti CTLA4 PE_Attune BioLegend RRID: AB_313254 Anti CD45 BUV395_Cytek BD RRID: AB_2651134 Anti CD4 BUV496_Cytek BD RRID: AB_2970666 Anti Ly6G BUV563_Cytek BD Cat# 612921 Anti CD11b BUV661_Cytek BD Cat# 612977 Anti CD8a_Cytek Invitrogen Cat# 368-0081-82 Anti B220_Cytek BioLegend RRID: AB_492877 Anti CD25_Cytek Invitrogen Cat# 69-0251-82; RRID: AB_2762802 Anti XCR1_Cytek BioLegend RRID: AB_566410 Anti NK1.1_Cytek BioLegend RRID: AB_2563286 Anti Siglec H_Cytek BD RRID: AB_2744231 Anti Siglec F_Cytek BD RRID: AB_2738833 Anti CD64 AF532_Cytek Novus Biologicals Cat# NB039151 Anti Ly6c PerCP_Cytek BioLegend RRID: AB_10900235 Anti MHC II BB700_Cytek BD RRID: AB_2743544 Anti CCR2 PE_Cytek BioLegend RRID: AB_2616981 Anti CD11c PE/Dazzle 594_Cytek BioLegend RRID: AB_2563654 Anti F4/80 PE/Cy5_Cytek BioLegend RRID: AB_893494 Anti CD172a PE/Cy7_Cytek BioLegend RRID: AB_2563545 Anti FOXP3 FITC_Cytek Invitrogen Cat# 11-5773-82; RRID: AB_465243 Anti CD3 APC_Cytek BioLegend RRID: AB_2561455 Anti CD90 AF700_Cytek R&D System Cat# FAB7335N-100UG Hu14.18K322A St. Jude Children’s Research Hospital N/A (Continued on next page) Cell Reports 42, 113556, December 26, 2023 19 .. REAGENT or RESOURCE SOURCE IDENTIFIER Cetuximab (Erbitux, anti huEGFR antibody) Eli Lilly N/A Anti PD-L1 (in vivo) BioXcell RRID: AB10949073 Anti CTLA4 (in vivo) BioXcell RRID: AB10949609 CD8 depletion antibody (in vivo) BioXcell RRID: AB1125541 CD4 depletion antibody (in vivo) BioXcell RRID: AB1107636 NK depletion antibody (in vivo) BioXcell RRID: AB1107737 Biological samples Healthy donor PBMCs Stem Cell Cat# 200-0093 Patients PBMCs This paper UW16134 Chemicals, peptides, and Recombinant:Article Title: NK cells propagate T cell immunity following in situ tumor vaccination. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti CD45 PE-Cy7_Attune BioLegend RRID: AB_312978 Anti CD3 FITC_Attune BioLegend RRID: AB_312660 Anti CD4 BV510_Attune BioLegend RRID: AB_2561388 Anti CD8 PerCP-Cy5.5_Attune BioLegend RRID: AB_2075239 Anti NK1.1 BV605_Attune BioLegend RRID: AB_2562273 Anti CD25 BV711_Attune BioLegend RRID: AB_2564130 Anti FOXP3 BV421_Attune BioLegend RRID: AB_2565933 Anti CXCR3 APC_Attune BioLegend RRID: AB_2814077 Anti CD44 BV605_Attune BioLegend RRID: AB_2562451 Anti CD44 BV711_Attune BioLegend RRID: AB_2564214 Anti CD62L AF700_Attune BioLegend RRID: AB_493719 Anti H-2 FITC_Attune BioLegend RRID: AB_1236475 Anti TNFa BV711_Attune BioLegend RRID: AB_2629800 Anti TNFa PE_Attune BioLegend RRID: AB_315426 Anti IFNg APC_Attune BioLegend RRID: AB_315403 Anti PD-L1 PerCP-Cy5.5_Attune BioLegend RRID: AB_2629831 Anti PD-1 BV421_Attune BioLegend RRID: AB_10900085 Anti CD86 blocking Ab_Attune BioLegend RRID: AB_2888740 Anti CD86 PE_Attune BioLegend RRID: AB_2832567 Anti CTLA4 BV421_Attune BioLegend RRID: AB_2616790 Anti CTLA4 PE_Attune BioLegend RRID: AB_313254 Anti CD45 BUV395_Cytek BD RRID: AB_2651134 Anti CD4 BUV496_Cytek BD RRID: AB_2970666 Anti Ly6G BUV563_Cytek BD Cat# 612921 Anti CD11b BUV661_Cytek BD Cat# 612977 Anti CD8a_Cytek Invitrogen Cat# 368-0081-82 Anti B220_Cytek BioLegend RRID: AB_492877 Anti CD25_Cytek Invitrogen Cat# 69-0251-82; RRID: AB_2762802 Anti XCR1_Cytek BioLegend RRID: AB_566410 Anti NK1.1_Cytek BioLegend RRID: AB_2563286 Anti Siglec H_Cytek BD RRID: AB_2744231 Anti Siglec F_Cytek BD RRID: AB_2738833 Anti CD64 AF532_Cytek Novus Biologicals Cat# NB039151 Anti Ly6c PerCP_Cytek BioLegend RRID: AB_10900235 Anti MHC II BB700_Cytek BD RRID: AB_2743544 Anti CCR2 PE_Cytek BioLegend RRID: AB_2616981 Anti CD11c PE/Dazzle 594_Cytek BioLegend RRID: AB_2563654 Anti F4/80 PE/Cy5_Cytek BioLegend RRID: AB_893494 Anti CD172a PE/Cy7_Cytek BioLegend RRID: AB_2563545 Anti FOXP3 FITC_Cytek Invitrogen Cat# 11-5773-82; RRID: AB_465243 Anti CD3 APC_Cytek BioLegend RRID: AB_2561455 Anti CD90 AF700_Cytek R&D System Cat# FAB7335N-100UG Hu14.18K322A St. Jude Children’s Research Hospital N/A (Continued on next page) Cell Reports 42, 113556, December 26, 2023 19 .. REAGENT or RESOURCE SOURCE IDENTIFIER Cetuximab (Erbitux, anti huEGFR antibody) Eli Lilly N/A Anti PD-L1 (in vivo) BioXcell RRID: AB10949073 Anti CTLA4 (in vivo) BioXcell RRID: AB10949609 CD8 depletion antibody (in vivo) BioXcell RRID: AB1125541 CD4 depletion antibody (in vivo) BioXcell RRID: AB1107636 NK depletion antibody (in vivo) BioXcell RRID: AB1107737 Biological samples Healthy donor PBMCs Stem Cell Cat# 200-0093 Patients PBMCs This paper UW16134 Chemicals, peptides, and Multiplex Assay:Article Title: NK cells propagate T cell immunity following in situ tumor vaccination. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti CD45 PE-Cy7_Attune BioLegend RRID: AB_312978 Anti CD3 FITC_Attune BioLegend RRID: AB_312660 Anti CD4 BV510_Attune BioLegend RRID: AB_2561388 Anti CD8 PerCP-Cy5.5_Attune BioLegend RRID: AB_2075239 Anti NK1.1 BV605_Attune BioLegend RRID: AB_2562273 Anti CD25 BV711_Attune BioLegend RRID: AB_2564130 Anti FOXP3 BV421_Attune BioLegend RRID: AB_2565933 Anti CXCR3 APC_Attune BioLegend RRID: AB_2814077 Anti CD44 BV605_Attune BioLegend RRID: AB_2562451 Anti CD44 BV711_Attune BioLegend RRID: AB_2564214 Anti CD62L AF700_Attune BioLegend RRID: AB_493719 Anti H-2 FITC_Attune BioLegend RRID: AB_1236475 Anti TNFa BV711_Attune BioLegend RRID: AB_2629800 Anti TNFa PE_Attune BioLegend RRID: AB_315426 Anti IFNg APC_Attune BioLegend RRID: AB_315403 Anti PD-L1 PerCP-Cy5.5_Attune BioLegend RRID: AB_2629831 Anti PD-1 BV421_Attune BioLegend RRID: AB_10900085 Anti CD86 blocking Ab_Attune BioLegend RRID: AB_2888740 Anti CD86 PE_Attune BioLegend RRID: AB_2832567 Anti CTLA4 BV421_Attune BioLegend RRID: AB_2616790 Anti CTLA4 PE_Attune BioLegend RRID: AB_313254 Anti CD45 BUV395_Cytek BD RRID: AB_2651134 Anti CD4 BUV496_Cytek BD RRID: AB_2970666 Anti Ly6G BUV563_Cytek BD Cat# 612921 Anti CD11b BUV661_Cytek BD Cat# 612977 Anti CD8a_Cytek Invitrogen Cat# 368-0081-82 Anti B220_Cytek BioLegend RRID: AB_492877 Anti CD25_Cytek Invitrogen Cat# 69-0251-82; RRID: AB_2762802 Anti XCR1_Cytek BioLegend RRID: AB_566410 Anti NK1.1_Cytek BioLegend RRID: AB_2563286 Anti Siglec H_Cytek BD RRID: AB_2744231 Anti Siglec F_Cytek BD RRID: AB_2738833 Anti CD64 AF532_Cytek Novus Biologicals Cat# NB039151 Anti Ly6c PerCP_Cytek BioLegend RRID: AB_10900235 Anti MHC II BB700_Cytek BD RRID: AB_2743544 Anti CCR2 PE_Cytek BioLegend RRID: AB_2616981 Anti CD11c PE/Dazzle 594_Cytek BioLegend RRID: AB_2563654 Anti F4/80 PE/Cy5_Cytek BioLegend RRID: AB_893494 Anti CD172a PE/Cy7_Cytek BioLegend RRID: AB_2563545 Anti FOXP3 FITC_Cytek Invitrogen Cat# 11-5773-82; RRID: AB_465243 Anti CD3 APC_Cytek BioLegend RRID: AB_2561455 Anti CD90 AF700_Cytek R&D System Cat# FAB7335N-100UG Hu14.18K322A St. Jude Children’s Research Hospital N/A (Continued on next page) Cell Reports 42, 113556, December 26, 2023 19 .. REAGENT or RESOURCE SOURCE IDENTIFIER Cetuximab (Erbitux, anti huEGFR antibody) Eli Lilly N/A Anti PD-L1 (in vivo) BioXcell RRID: AB10949073 Anti CTLA4 (in vivo) BioXcell RRID: AB10949609 CD8 depletion antibody (in vivo) BioXcell RRID: AB1125541 CD4 depletion antibody (in vivo) BioXcell RRID: AB1107636 NK depletion antibody (in vivo) BioXcell RRID: AB1107737 Biological samples Healthy donor PBMCs Stem Cell Cat# 200-0093 Patients PBMCs This paper UW16134 Chemicals, peptides, and Enzyme-linked Immunosorbent Assay:Article Title: NK cells propagate T cell immunity following in situ tumor vaccination. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti CD45 PE-Cy7_Attune BioLegend RRID: AB_312978 Anti CD3 FITC_Attune BioLegend RRID: AB_312660 Anti CD4 BV510_Attune BioLegend RRID: AB_2561388 Anti CD8 PerCP-Cy5.5_Attune BioLegend RRID: AB_2075239 Anti NK1.1 BV605_Attune BioLegend RRID: AB_2562273 Anti CD25 BV711_Attune BioLegend RRID: AB_2564130 Anti FOXP3 BV421_Attune BioLegend RRID: AB_2565933 Anti CXCR3 APC_Attune BioLegend RRID: AB_2814077 Anti CD44 BV605_Attune BioLegend RRID: AB_2562451 Anti CD44 BV711_Attune BioLegend RRID: AB_2564214 Anti CD62L AF700_Attune BioLegend RRID: AB_493719 Anti H-2 FITC_Attune BioLegend RRID: AB_1236475 Anti TNFa BV711_Attune BioLegend RRID: AB_2629800 Anti TNFa PE_Attune BioLegend RRID: AB_315426 Anti IFNg APC_Attune BioLegend RRID: AB_315403 Anti PD-L1 PerCP-Cy5.5_Attune BioLegend RRID: AB_2629831 Anti PD-1 BV421_Attune BioLegend RRID: AB_10900085 Anti CD86 blocking Ab_Attune BioLegend RRID: AB_2888740 Anti CD86 PE_Attune BioLegend RRID: AB_2832567 Anti CTLA4 BV421_Attune BioLegend RRID: AB_2616790 Anti CTLA4 PE_Attune BioLegend RRID: AB_313254 Anti CD45 BUV395_Cytek BD RRID: AB_2651134 Anti CD4 BUV496_Cytek BD RRID: AB_2970666 Anti Ly6G BUV563_Cytek BD Cat# 612921 Anti CD11b BUV661_Cytek BD Cat# 612977 Anti CD8a_Cytek Invitrogen Cat# 368-0081-82 Anti B220_Cytek BioLegend RRID: AB_492877 Anti CD25_Cytek Invitrogen Cat# 69-0251-82; RRID: AB_2762802 Anti XCR1_Cytek BioLegend RRID: AB_566410 Anti NK1.1_Cytek BioLegend RRID: AB_2563286 Anti Siglec H_Cytek BD RRID: AB_2744231 Anti Siglec F_Cytek BD RRID: AB_2738833 Anti CD64 AF532_Cytek Novus Biologicals Cat# NB039151 Anti Ly6c PerCP_Cytek BioLegend RRID: AB_10900235 Anti MHC II BB700_Cytek BD RRID: AB_2743544 Anti CCR2 PE_Cytek BioLegend RRID: AB_2616981 Anti CD11c PE/Dazzle 594_Cytek BioLegend RRID: AB_2563654 Anti F4/80 PE/Cy5_Cytek BioLegend RRID: AB_893494 Anti CD172a PE/Cy7_Cytek BioLegend RRID: AB_2563545 Anti FOXP3 FITC_Cytek Invitrogen Cat# 11-5773-82; RRID: AB_465243 Anti CD3 APC_Cytek BioLegend RRID: AB_2561455 Anti CD90 AF700_Cytek R&D System Cat# FAB7335N-100UG Hu14.18K322A St. Jude Children’s Research Hospital N/A (Continued on next page) Cell Reports 42, 113556, December 26, 2023 19 .. REAGENT or RESOURCE SOURCE IDENTIFIER Cetuximab (Erbitux, anti huEGFR antibody) Eli Lilly N/A Anti PD-L1 (in vivo) BioXcell RRID: AB10949073 Anti CTLA4 (in vivo) BioXcell RRID: AB10949609 CD8 depletion antibody (in vivo) BioXcell RRID: AB1125541 CD4 depletion antibody (in vivo) BioXcell RRID: AB1107636 NK depletion antibody (in vivo) BioXcell RRID: AB1107737 Biological samples Healthy donor PBMCs Stem Cell Cat# 200-0093 Patients PBMCs This paper UW16134 Chemicals, peptides, and Single Cell:Article Title: NK cells propagate T cell immunity following in situ tumor vaccination. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti CD45 PE-Cy7_Attune BioLegend RRID: AB_312978 Anti CD3 FITC_Attune BioLegend RRID: AB_312660 Anti CD4 BV510_Attune BioLegend RRID: AB_2561388 Anti CD8 PerCP-Cy5.5_Attune BioLegend RRID: AB_2075239 Anti NK1.1 BV605_Attune BioLegend RRID: AB_2562273 Anti CD25 BV711_Attune BioLegend RRID: AB_2564130 Anti FOXP3 BV421_Attune BioLegend RRID: AB_2565933 Anti CXCR3 APC_Attune BioLegend RRID: AB_2814077 Anti CD44 BV605_Attune BioLegend RRID: AB_2562451 Anti CD44 BV711_Attune BioLegend RRID: AB_2564214 Anti CD62L AF700_Attune BioLegend RRID: AB_493719 Anti H-2 FITC_Attune BioLegend RRID: AB_1236475 Anti TNFa BV711_Attune BioLegend RRID: AB_2629800 Anti TNFa PE_Attune BioLegend RRID: AB_315426 Anti IFNg APC_Attune BioLegend RRID: AB_315403 Anti PD-L1 PerCP-Cy5.5_Attune BioLegend RRID: AB_2629831 Anti PD-1 BV421_Attune BioLegend RRID: AB_10900085 Anti CD86 blocking Ab_Attune BioLegend RRID: AB_2888740 Anti CD86 PE_Attune BioLegend RRID: AB_2832567 Anti CTLA4 BV421_Attune BioLegend RRID: AB_2616790 Anti CTLA4 PE_Attune BioLegend RRID: AB_313254 Anti CD45 BUV395_Cytek BD RRID: AB_2651134 Anti CD4 BUV496_Cytek BD RRID: AB_2970666 Anti Ly6G BUV563_Cytek BD Cat# 612921 Anti CD11b BUV661_Cytek BD Cat# 612977 Anti CD8a_Cytek Invitrogen Cat# 368-0081-82 Anti B220_Cytek BioLegend RRID: AB_492877 Anti CD25_Cytek Invitrogen Cat# 69-0251-82; RRID: AB_2762802 Anti XCR1_Cytek BioLegend RRID: AB_566410 Anti NK1.1_Cytek BioLegend RRID: AB_2563286 Anti Siglec H_Cytek BD RRID: AB_2744231 Anti Siglec F_Cytek BD RRID: AB_2738833 Anti CD64 AF532_Cytek Novus Biologicals Cat# NB039151 Anti Ly6c PerCP_Cytek BioLegend RRID: AB_10900235 Anti MHC II BB700_Cytek BD RRID: AB_2743544 Anti CCR2 PE_Cytek BioLegend RRID: AB_2616981 Anti CD11c PE/Dazzle 594_Cytek BioLegend RRID: AB_2563654 Anti F4/80 PE/Cy5_Cytek BioLegend RRID: AB_893494 Anti CD172a PE/Cy7_Cytek BioLegend RRID: AB_2563545 Anti FOXP3 FITC_Cytek Invitrogen Cat# 11-5773-82; RRID: AB_465243 Anti CD3 APC_Cytek BioLegend RRID: AB_2561455 Anti CD90 AF700_Cytek R&D System Cat# FAB7335N-100UG Hu14.18K322A St. Jude Children’s Research Hospital N/A (Continued on next page) Cell Reports 42, 113556, December 26, 2023 19 .. REAGENT or RESOURCE SOURCE IDENTIFIER Cetuximab (Erbitux, anti huEGFR antibody) Eli Lilly N/A Anti PD-L1 (in vivo) BioXcell RRID: AB10949073 Anti CTLA4 (in vivo) BioXcell RRID: AB10949609 CD8 depletion antibody (in vivo) BioXcell RRID: AB1125541 CD4 depletion antibody (in vivo) BioXcell RRID: AB1107636 NK depletion antibody (in vivo) BioXcell RRID: AB1107737 Biological samples Healthy donor PBMCs Stem Cell Cat# 200-0093 Patients PBMCs This paper UW16134 Chemicals, peptides, and Cell Isolation:Article Title: NK cells propagate T cell immunity following in situ tumor vaccination. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti CD45 PE-Cy7_Attune BioLegend RRID: AB_312978 Anti CD3 FITC_Attune BioLegend RRID: AB_312660 Anti CD4 BV510_Attune BioLegend RRID: AB_2561388 Anti CD8 PerCP-Cy5.5_Attune BioLegend RRID: AB_2075239 Anti NK1.1 BV605_Attune BioLegend RRID: AB_2562273 Anti CD25 BV711_Attune BioLegend RRID: AB_2564130 Anti FOXP3 BV421_Attune BioLegend RRID: AB_2565933 Anti CXCR3 APC_Attune BioLegend RRID: AB_2814077 Anti CD44 BV605_Attune BioLegend RRID: AB_2562451 Anti CD44 BV711_Attune BioLegend RRID: AB_2564214 Anti CD62L AF700_Attune BioLegend RRID: AB_493719 Anti H-2 FITC_Attune BioLegend RRID: AB_1236475 Anti TNFa BV711_Attune BioLegend RRID: AB_2629800 Anti TNFa PE_Attune BioLegend RRID: AB_315426 Anti IFNg APC_Attune BioLegend RRID: AB_315403 Anti PD-L1 PerCP-Cy5.5_Attune BioLegend RRID: AB_2629831 Anti PD-1 BV421_Attune BioLegend RRID: AB_10900085 Anti CD86 blocking Ab_Attune BioLegend RRID: AB_2888740 Anti CD86 PE_Attune BioLegend RRID: AB_2832567 Anti CTLA4 BV421_Attune BioLegend RRID: AB_2616790 Anti CTLA4 PE_Attune BioLegend RRID: AB_313254 Anti CD45 BUV395_Cytek BD RRID: AB_2651134 Anti CD4 BUV496_Cytek BD RRID: AB_2970666 Anti Ly6G BUV563_Cytek BD Cat# 612921 Anti CD11b BUV661_Cytek BD Cat# 612977 Anti CD8a_Cytek Invitrogen Cat# 368-0081-82 Anti B220_Cytek BioLegend RRID: AB_492877 Anti CD25_Cytek Invitrogen Cat# 69-0251-82; RRID: AB_2762802 Anti XCR1_Cytek BioLegend RRID: AB_566410 Anti NK1.1_Cytek BioLegend RRID: AB_2563286 Anti Siglec H_Cytek BD RRID: AB_2744231 Anti Siglec F_Cytek BD RRID: AB_2738833 Anti CD64 AF532_Cytek Novus Biologicals Cat# NB039151 Anti Ly6c PerCP_Cytek BioLegend RRID: AB_10900235 Anti MHC II BB700_Cytek BD RRID: AB_2743544 Anti CCR2 PE_Cytek BioLegend RRID: AB_2616981 Anti CD11c PE/Dazzle 594_Cytek BioLegend RRID: AB_2563654 Anti F4/80 PE/Cy5_Cytek BioLegend RRID: AB_893494 Anti CD172a PE/Cy7_Cytek BioLegend RRID: AB_2563545 Anti FOXP3 FITC_Cytek Invitrogen Cat# 11-5773-82; RRID: AB_465243 Anti CD3 APC_Cytek BioLegend RRID: AB_2561455 Anti CD90 AF700_Cytek R&D System Cat# FAB7335N-100UG Hu14.18K322A St. Jude Children’s Research Hospital N/A (Continued on next page) Cell Reports 42, 113556, December 26, 2023 19 .. REAGENT or RESOURCE SOURCE IDENTIFIER Cetuximab (Erbitux, anti huEGFR antibody) Eli Lilly N/A Anti PD-L1 (in vivo) BioXcell RRID: AB10949073 Anti CTLA4 (in vivo) BioXcell RRID: AB10949609 CD8 depletion antibody (in vivo) BioXcell RRID: AB1125541 CD4 depletion antibody (in vivo) BioXcell RRID: AB1107636 NK depletion antibody (in vivo) BioXcell RRID: AB1107737 Biological samples Healthy donor PBMCs Stem Cell Cat# 200-0093 Patients PBMCs This paper UW16134 Chemicals, peptides, and RNA Sequencing:Article Title: NK cells propagate T cell immunity following in situ tumor vaccination. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti CD45 PE-Cy7_Attune BioLegend RRID: AB_312978 Anti CD3 FITC_Attune BioLegend RRID: AB_312660 Anti CD4 BV510_Attune BioLegend RRID: AB_2561388 Anti CD8 PerCP-Cy5.5_Attune BioLegend RRID: AB_2075239 Anti NK1.1 BV605_Attune BioLegend RRID: AB_2562273 Anti CD25 BV711_Attune BioLegend RRID: AB_2564130 Anti FOXP3 BV421_Attune BioLegend RRID: AB_2565933 Anti CXCR3 APC_Attune BioLegend RRID: AB_2814077 Anti CD44 BV605_Attune BioLegend RRID: AB_2562451 Anti CD44 BV711_Attune BioLegend RRID: AB_2564214 Anti CD62L AF700_Attune BioLegend RRID: AB_493719 Anti H-2 FITC_Attune BioLegend RRID: AB_1236475 Anti TNFa BV711_Attune BioLegend RRID: AB_2629800 Anti TNFa PE_Attune BioLegend RRID: AB_315426 Anti IFNg APC_Attune BioLegend RRID: AB_315403 Anti PD-L1 PerCP-Cy5.5_Attune BioLegend RRID: AB_2629831 Anti PD-1 BV421_Attune BioLegend RRID: AB_10900085 Anti CD86 blocking Ab_Attune BioLegend RRID: AB_2888740 Anti CD86 PE_Attune BioLegend RRID: AB_2832567 Anti CTLA4 BV421_Attune BioLegend RRID: AB_2616790 Anti CTLA4 PE_Attune BioLegend RRID: AB_313254 Anti CD45 BUV395_Cytek BD RRID: AB_2651134 Anti CD4 BUV496_Cytek BD RRID: AB_2970666 Anti Ly6G BUV563_Cytek BD Cat# 612921 Anti CD11b BUV661_Cytek BD Cat# 612977 Anti CD8a_Cytek Invitrogen Cat# 368-0081-82 Anti B220_Cytek BioLegend RRID: AB_492877 Anti CD25_Cytek Invitrogen Cat# 69-0251-82; RRID: AB_2762802 Anti XCR1_Cytek BioLegend RRID: AB_566410 Anti NK1.1_Cytek BioLegend RRID: AB_2563286 Anti Siglec H_Cytek BD RRID: AB_2744231 Anti Siglec F_Cytek BD RRID: AB_2738833 Anti CD64 AF532_Cytek Novus Biologicals Cat# NB039151 Anti Ly6c PerCP_Cytek BioLegend RRID: AB_10900235 Anti MHC II BB700_Cytek BD RRID: AB_2743544 Anti CCR2 PE_Cytek BioLegend RRID: AB_2616981 Anti CD11c PE/Dazzle 594_Cytek BioLegend RRID: AB_2563654 Anti F4/80 PE/Cy5_Cytek BioLegend RRID: AB_893494 Anti CD172a PE/Cy7_Cytek BioLegend RRID: AB_2563545 Anti FOXP3 FITC_Cytek Invitrogen Cat# 11-5773-82; RRID: AB_465243 Anti CD3 APC_Cytek BioLegend RRID: AB_2561455 Anti CD90 AF700_Cytek R&D System Cat# FAB7335N-100UG Hu14.18K322A St. Jude Children’s Research Hospital N/A (Continued on next page) Cell Reports 42, 113556, December 26, 2023 19 .. REAGENT or RESOURCE SOURCE IDENTIFIER Cetuximab (Erbitux, anti huEGFR antibody) Eli Lilly N/A Anti PD-L1 (in vivo) BioXcell RRID: AB10949073 Anti CTLA4 (in vivo) BioXcell RRID: AB10949609 CD8 depletion antibody (in vivo) BioXcell RRID: AB1125541 CD4 depletion antibody (in vivo) BioXcell RRID: AB1107636 NK depletion antibody (in vivo) BioXcell RRID: AB1107737 Biological samples Healthy donor PBMCs Stem Cell Cat# 200-0093 Patients PBMCs This paper UW16134 Chemicals, peptides, and CRISPR:Article Title: NK cells propagate T cell immunity following in situ tumor vaccination. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti CD45 PE-Cy7_Attune BioLegend RRID: AB_312978 Anti CD3 FITC_Attune BioLegend RRID: AB_312660 Anti CD4 BV510_Attune BioLegend RRID: AB_2561388 Anti CD8 PerCP-Cy5.5_Attune BioLegend RRID: AB_2075239 Anti NK1.1 BV605_Attune BioLegend RRID: AB_2562273 Anti CD25 BV711_Attune BioLegend RRID: AB_2564130 Anti FOXP3 BV421_Attune BioLegend RRID: AB_2565933 Anti CXCR3 APC_Attune BioLegend RRID: AB_2814077 Anti CD44 BV605_Attune BioLegend RRID: AB_2562451 Anti CD44 BV711_Attune BioLegend RRID: AB_2564214 Anti CD62L AF700_Attune BioLegend RRID: AB_493719 Anti H-2 FITC_Attune BioLegend RRID: AB_1236475 Anti TNFa BV711_Attune BioLegend RRID: AB_2629800 Anti TNFa PE_Attune BioLegend RRID: AB_315426 Anti IFNg APC_Attune BioLegend RRID: AB_315403 Anti PD-L1 PerCP-Cy5.5_Attune BioLegend RRID: AB_2629831 Anti PD-1 BV421_Attune BioLegend RRID: AB_10900085 Anti CD86 blocking Ab_Attune BioLegend RRID: AB_2888740 Anti CD86 PE_Attune BioLegend RRID: AB_2832567 Anti CTLA4 BV421_Attune BioLegend RRID: AB_2616790 Anti CTLA4 PE_Attune BioLegend RRID: AB_313254 Anti CD45 BUV395_Cytek BD RRID: AB_2651134 Anti CD4 BUV496_Cytek BD RRID: AB_2970666 Anti Ly6G BUV563_Cytek BD Cat# 612921 Anti CD11b BUV661_Cytek BD Cat# 612977 Anti CD8a_Cytek Invitrogen Cat# 368-0081-82 Anti B220_Cytek BioLegend RRID: AB_492877 Anti CD25_Cytek Invitrogen Cat# 69-0251-82; RRID: AB_2762802 Anti XCR1_Cytek BioLegend RRID: AB_566410 Anti NK1.1_Cytek BioLegend RRID: AB_2563286 Anti Siglec H_Cytek BD RRID: AB_2744231 Anti Siglec F_Cytek BD RRID: AB_2738833 Anti CD64 AF532_Cytek Novus Biologicals Cat# NB039151 Anti Ly6c PerCP_Cytek BioLegend RRID: AB_10900235 Anti MHC II BB700_Cytek BD RRID: AB_2743544 Anti CCR2 PE_Cytek BioLegend RRID: AB_2616981 Anti CD11c PE/Dazzle 594_Cytek BioLegend RRID: AB_2563654 Anti F4/80 PE/Cy5_Cytek BioLegend RRID: AB_893494 Anti CD172a PE/Cy7_Cytek BioLegend RRID: AB_2563545 Anti FOXP3 FITC_Cytek Invitrogen Cat# 11-5773-82; RRID: AB_465243 Anti CD3 APC_Cytek BioLegend RRID: AB_2561455 Anti CD90 AF700_Cytek R&D System Cat# FAB7335N-100UG Hu14.18K322A St. Jude Children’s Research Hospital N/A (Continued on next page) Cell Reports 42, 113556, December 26, 2023 19 .. REAGENT or RESOURCE SOURCE IDENTIFIER Cetuximab (Erbitux, anti huEGFR antibody) Eli Lilly N/A Anti PD-L1 (in vivo) BioXcell RRID: AB10949073 Anti CTLA4 (in vivo) BioXcell RRID: AB10949609 CD8 depletion antibody (in vivo) BioXcell RRID: AB1125541 CD4 depletion antibody (in vivo) BioXcell RRID: AB1107636 NK depletion antibody (in vivo) BioXcell RRID: AB1107737 Biological samples Healthy donor PBMCs Stem Cell Cat# 200-0093 Patients PBMCs This paper UW16134 Chemicals, peptides, and Software:Article Title: NK cells propagate T cell immunity following in situ tumor vaccination. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti CD45 PE-Cy7_Attune BioLegend RRID: AB_312978 Anti CD3 FITC_Attune BioLegend RRID: AB_312660 Anti CD4 BV510_Attune BioLegend RRID: AB_2561388 Anti CD8 PerCP-Cy5.5_Attune BioLegend RRID: AB_2075239 Anti NK1.1 BV605_Attune BioLegend RRID: AB_2562273 Anti CD25 BV711_Attune BioLegend RRID: AB_2564130 Anti FOXP3 BV421_Attune BioLegend RRID: AB_2565933 Anti CXCR3 APC_Attune BioLegend RRID: AB_2814077 Anti CD44 BV605_Attune BioLegend RRID: AB_2562451 Anti CD44 BV711_Attune BioLegend RRID: AB_2564214 Anti CD62L AF700_Attune BioLegend RRID: AB_493719 Anti H-2 FITC_Attune BioLegend RRID: AB_1236475 Anti TNFa BV711_Attune BioLegend RRID: AB_2629800 Anti TNFa PE_Attune BioLegend RRID: AB_315426 Anti IFNg APC_Attune BioLegend RRID: AB_315403 Anti PD-L1 PerCP-Cy5.5_Attune BioLegend RRID: AB_2629831 Anti PD-1 BV421_Attune BioLegend RRID: AB_10900085 Anti CD86 blocking Ab_Attune BioLegend RRID: AB_2888740 Anti CD86 PE_Attune BioLegend RRID: AB_2832567 Anti CTLA4 BV421_Attune BioLegend RRID: AB_2616790 Anti CTLA4 PE_Attune BioLegend RRID: AB_313254 Anti CD45 BUV395_Cytek BD RRID: AB_2651134 Anti CD4 BUV496_Cytek BD RRID: AB_2970666 Anti Ly6G BUV563_Cytek BD Cat# 612921 Anti CD11b BUV661_Cytek BD Cat# 612977 Anti CD8a_Cytek Invitrogen Cat# 368-0081-82 Anti B220_Cytek BioLegend RRID: AB_492877 Anti CD25_Cytek Invitrogen Cat# 69-0251-82; RRID: AB_2762802 Anti XCR1_Cytek BioLegend RRID: AB_566410 Anti NK1.1_Cytek BioLegend RRID: AB_2563286 Anti Siglec H_Cytek BD RRID: AB_2744231 Anti Siglec F_Cytek BD RRID: AB_2738833 Anti CD64 AF532_Cytek Novus Biologicals Cat# NB039151 Anti Ly6c PerCP_Cytek BioLegend RRID: AB_10900235 Anti MHC II BB700_Cytek BD RRID: AB_2743544 Anti CCR2 PE_Cytek BioLegend RRID: AB_2616981 Anti CD11c PE/Dazzle 594_Cytek BioLegend RRID: AB_2563654 Anti F4/80 PE/Cy5_Cytek BioLegend RRID: AB_893494 Anti CD172a PE/Cy7_Cytek BioLegend RRID: AB_2563545 Anti FOXP3 FITC_Cytek Invitrogen Cat# 11-5773-82; RRID: AB_465243 Anti CD3 APC_Cytek BioLegend RRID: AB_2561455 Anti CD90 AF700_Cytek R&D System Cat# FAB7335N-100UG Hu14.18K322A St. Jude Children’s Research Hospital N/A (Continued on next page) Cell Reports 42, 113556, December 26, 2023 19 .. REAGENT or RESOURCE SOURCE IDENTIFIER Cetuximab (Erbitux, anti huEGFR antibody) Eli Lilly N/A Anti PD-L1 (in vivo) BioXcell RRID: AB10949073 Anti CTLA4 (in vivo) BioXcell RRID: AB10949609 CD8 depletion antibody (in vivo) BioXcell RRID: AB1125541 CD4 depletion antibody (in vivo) BioXcell RRID: AB1107636 NK depletion antibody (in vivo) BioXcell RRID: AB1107737 Biological samples Healthy donor PBMCs Stem Cell Cat# 200-0093 Patients PBMCs This paper UW16134 Chemicals, peptides, and |